Key result
Adaptive cardiac hypertrophy maintains or upregulates β1-adrenoceptor signaling while maladaptive hypertrophy and HF downregulate it.
Highlights the potential critical role of autonomic imbalance in the beta-1 adrenoceptor signal transduction system alterations seen in heart failure.
May aid differentiation of adaptive versus maladaptive hypertrophy; leaves open whether β1-adrenoceptor targeting alters progression to heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dhalla et al. (2023) conducted a review in Cardiac Hypertrophy and Heart Failure. Adaptive cardiac hypertrophy shows unaltered or upregulated β1-adrenoceptor signaling, whereas maladaptive hypertrophy and heart failure exhibit downregulated β1-adrenoceptor mechanisms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: